Last 12 months
- April 2024 (0)
- March 2024 (4)
- February 2024 (4)
- January 2024 (2)
- December 2023 (2)
- November 2023 (0)
- October 2023 (1)
- September 2023 (1)
- August 2023 (1)
- July 2023 (0)
- June 2023 (1)
- May 2023 (1)
- Show All
Tags
- Infection (1)
- Visiting Speaker Program (4)
- Immunology (105)
- Closing Soon (4)
- Journals (18)
- Special Interest Groups (3)
- Immunology & Cell Biology (25)
- Women's Initiative (10)
- ASI Awards (65)
- Clinical & Translational Immunology (9)
- ASI (103)
- Day of Immunology (18)
- Competition (10)
- ASI Membership (26)
- Vaccines (32)
- Event/Meeting (47)
- Show All
Latest News
Tuesday February 07, 2023
Congratulations to Kate Schroder,
2022 ASI AbbVie New Horizons Research Awardee
In 2022 we continued our partnership with AbbVie in bringing you the ASI AbbVie New Horizons Research Award.
We warmly congratulate
Kate Schroder
winner of the 2022 ASI AbbVie New Horizons Research Award.
We extend much gratitude to AbbVie, who have generously sponsored this prestigious award.
AbbVie is a global biopharmaceutical company committed to developing innovative therapies for some of the world’s most complex conditions. In Australia, we employ more than 450 people with our therapies currently benefiting more than 30,000 Australians across several therapeutic areas: Immunology, Oncology, Virology, Neuroscience, Eye Care and Aesthetics.
ASI AbbVie New Horizons Research Award
Background
AbbVie is committed to moving science forward to further develop medicines that can change the lives of people living with immune-mediated conditions such as Autoimmunity and Inflammation.
Within these therapeutic areas, AbbVie has identified gaps in immunology research, particularly in the areas of new biological pathways, druggable targets and biomarkers, leading to paucity of innovation in therapeutics and precision medicine.
To encourage investment in emerging areas, AbbVie will sponsor a research award that recognises an exceptional Australian or New Zealand Researcher who is leading in future-focused research that has potential to advance scientific exploration in emerging areas.
Purpose
To support a mid career research Immunologist (10-20 years post-doctoral) with potential to advance research in emerging areas such as new biological pathways, druggable targets and biomarkers, within the fields of Autoimmunity, Inflammation, and other Immune-mediated Diseases (excluding Infectious Diseases).
The key objective of the ASI AbbVie New Horizons Research Award is to invigorate basic, translational or applied research in these areas of strategic importance.
